Google’s AI arm led by Demis Hassabis makes it harder for its researchers to publish studies in major change in approach ...
Isomorphic Labs, the AI drug-discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital ...
Isomorphic Labs says it is advancing drug design programs across multiple therapeutic areas and drug modalities. These ...
Their DeepMind synth proved to be a great, all-analogue success, but its eagerly awaited new version looks like a step ...
Google DeepMind launches TxGemma, open AI models to speed up drug discovery, enhance predictions, and support multi-step ...
Investing.com-- Google’s (NASDAQ: GOOGL) artificial intelligence research arm, DeepMind, has imposed stricter controls on the ...
Isomorphic Labs, the drug discovery start-up spun out of Google’s DeepMind artificial intelligence unit, has raised $600mn in its first external funding round, as investors bet on the potential for AI ...
The company, which uses artificial intelligence to develop new treatments, now counts the venture capital firm Thrive Capital ...
The London-based business – which launched in 2021 – will use the funds to further its research, expand its team and continue ...
Demis Hassabis, a childhood chess prodigy, said his experience with the game afforded him his first brush with AI. He was ...
Google DeepMind CEO Demis Hassabis's AI journey had an unexpected start: his early mastery of chess. Years before Hassabis ...
Nvidia has invested in a startup founded by a former Google DeepMind senior research scientist who specialized in robotics ...